Rabeprazole D4
Modify Date: 2024-01-08 15:33:22
Rabeprazole D4 structure
|
Common Name | Rabeprazole D4 | ||
|---|---|---|---|---|
| CAS Number | 934295-48-4 | Molecular Weight | 359.44300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H17D4N3O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Rabeprazole D4Rabeprazole D4 (LY307640 D4) is a deuterium labeled Rabeprazole. Rabeprazole is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole induces apoptosis. Rabeprazole acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole can be used for the research of gastric ulcerations and gastroesophageal reflux[1][2][3]. |
| Name | 1H-Benzimidazole-4,5,6,7-d4, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl] |
|---|---|
| Synonym | More Synonyms |
| Description | Rabeprazole D4 (LY307640 D4) is a deuterium labeled Rabeprazole. Rabeprazole is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole induces apoptosis. Rabeprazole acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole can be used for the research of gastric ulcerations and gastroesophageal reflux[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
Pump inhibitor (PPI); UNH[1] H+/K+-ATPase; Apoptosis[2] |
| References |
| Molecular Formula | C18H17D4N3O3S |
|---|---|
| Molecular Weight | 359.44300 |
| Exact Mass | 359.13000 |
| PSA | 96.31000 |
| LogP | 3.85510 |
| Hazard Codes | Xi |
|---|
| Rabeprazole-d4 |